138 related articles for article (PubMed ID: 19017177)
21. Innate and adaptive immune pathways to tolerance.
Thornton CA; Morgan G
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
[TBL] [Abstract][Full Text] [Related]
22. [Two cases of stomach primary diffuse large B cell lymphoma remitted by Helicobacter pylori eradication therapy].
Miyamoto S; Okamoto R; Maeda Y; Hishima T; Sasaki T
Gan To Kagaku Ryoho; 2008 Dec; 35(13):2437-40. PubMed ID: 19098419
[TBL] [Abstract][Full Text] [Related]
23. Diffuse large B-cell lymphomas and burkitt lymphoma.
de Leval L; Hasserjian RP
Hematol Oncol Clin North Am; 2009 Aug; 23(4):791-827. PubMed ID: 19577170
[TBL] [Abstract][Full Text] [Related]
24. Differentiating germinal center-derived lymphomas through their cellular microenvironment.
Carbone A; Gloghini A; Cabras A; Elia G
Am J Hematol; 2009 Jul; 84(7):435-8. PubMed ID: 19484731
[TBL] [Abstract][Full Text] [Related]
25. [The story about Hodgkin's lymphoma].
Ostojić Kolonić S
Acta Med Croatica; 2008 Oct; 62(4):409-12. PubMed ID: 19205418
[TBL] [Abstract][Full Text] [Related]
26. Histopathology of Hodgkin's lymphoma.
Eberle FC; Mani H; Jaffe ES
Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308
[TBL] [Abstract][Full Text] [Related]
27. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
[TBL] [Abstract][Full Text] [Related]
28. [The gastric MALT lymphoma. An unforeseen model for studying the pathogenesis of the lymphomas].
Savio A
Recenti Prog Med; 2009 Jun; 100(6):311-21. PubMed ID: 19708303
[TBL] [Abstract][Full Text] [Related]
29. Appraisal of immune response in lymphoproliferative syndromes: a systematic review.
Alvaro T; Lejeune M; Escrivá P; Pons LE; Bosch R; Jaén J; López C; Salvadó MT; de Sanjosé S
Crit Rev Oncol Hematol; 2009 May; 70(2):103-13. PubMed ID: 18996025
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.
Santacroce L; Cagiano R; Del Prete R; Bottalico L; Sabatini R; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Losacco T
Clin Ter; 2008; 159(6):457-62. PubMed ID: 19169609
[TBL] [Abstract][Full Text] [Related]
31. [Hodgkin's sarcoma and malignant lymphomas].
GELIN G
Bull Mem Soc Med Hop Paris; 1954 Mar 12-19; 70(9-10):259-67. PubMed ID: 13160799
[No Abstract] [Full Text] [Related]
32. Aspects of B-cell non-Hodgkin's lymphoma development: a transition from immune-reactivity to malignancy.
Illes A; Varoczy L; Papp G; Wilson PC; Alex P; Jonsson R; Kovacs T; Konttinen YT; Zeher M; Nakken B; Szodoray P
Scand J Immunol; 2009 May; 69(5):387-400. PubMed ID: 19508370
[TBL] [Abstract][Full Text] [Related]
33. Lymphomas and Their Microenvironment: A Multifaceted Relationship.
Menter T; Tzankov A
Pathobiology; 2019; 86(5-6):225-236. PubMed ID: 31574515
[TBL] [Abstract][Full Text] [Related]
34. [Passive transmission of the tuberculin allergy in sarcoidosis and in malignant lymphomas].
Kohout J
Wien Klin Wochenschr; 1967 Oct; 79(43):795-8. PubMed ID: 4872281
[No Abstract] [Full Text] [Related]
35. Prognostic factors in indolent and aggressive lymphomas and its influence on disease outcome.
Zodelava M; Betaneli M; Tsartsidze E; Kharabadze M
Georgian Med News; 2009 Feb; (167):32-6. PubMed ID: 19276466
[TBL] [Abstract][Full Text] [Related]
36. [Acquisitions and problems in the cellular and serum immunology of malignant blood diseases].
CAJANO A; FAIELLA A
Riv Emoter Immunoematol; 1960; 7():317-34. PubMed ID: 13689856
[No Abstract] [Full Text] [Related]
37. [A morphometric analysis of the nuclei and nucleoli in tumor cells in lymphogranulomatosis, diffuse large B-cell lymphoma and anaplastic large cell lymphoma].
Gorgidze LA; Vorob'ev IA
Ter Arkh; 2009; 81(2):71-5. PubMed ID: 19334496
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update.
Smedby KE; Askling J; Mariette X; Baecklund E
J Intern Med; 2008 Dec; 264(6):514-27. PubMed ID: 19017176
[TBL] [Abstract][Full Text] [Related]
39. Cathepsin X prevents an effective immune response against Helicobacter pylori infection.
Obermajer N; Magister S; Kopitar AN; Tepes B; Ihan A; Kos J
Eur J Cell Biol; 2009 Aug; 88(8):461-71. PubMed ID: 19446361
[TBL] [Abstract][Full Text] [Related]
40. Analysis of peripheral blood lymphocyte phenotypes and Th1/Th2 cytokines profile in the systemic immune responses of Helicobacter pylori infected individuals.
Kayhan B; Arasli M; Eren H; Aydemir S; Kayhan B; Aktas E; Tekin I
Microbiol Immunol; 2008 Nov; 52(11):531-8. PubMed ID: 19090832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
